FDA Finds Consumers Continue to Buy Potentially Risky Drugs Over the Internet

	Tweet

The U.S. Food and Drug Administration continues to warn the American public about the dangers of buying medications over the Internet.

New data collected by the FDA show that consumers who are trying to save money on prescription drugs don’t need to take chances by buying prescription drugs from foreign Internet sites, because low-cost generic versions are available in the United States. This finding also may be an indication that some consumers are likely buying foreign drugs this way to avoid getting a prescription from their doctor or health care professional, since many Web sites do not require a prescription. 

Safety Concerns
The use of prescription drugs without a prescription is an intrinsically unsafe practice. FDA urges consumers to have a prescription from their doctor or other health care professional before using prescription drugs. The agency also urges consumers to review www. fda.gov for important information before making such purchases.

Consumers should be aware of safety concerns of drugs purchased from unregulated Internet sellers since some of these drugs might:

* require careful dosing and monitoring;
* not have adequate labeling for safe use;
* be inappropriately packaged, therefore product integrity is uncertain;
* have been withdrawn from the U.S. market for safety or efficacy reasons;
* may carry risks that require initial screening and/or periodic patient monitoring;
* cause harm—such as a controlled substance (narcotic), whose use should be supervised by a doctor or health care professional due to abuse potential; and
* have clinically significant drug-drug interactions.

Recent examinations of a sample of drugs shipped to U.S. consumers found several drugs are associated with higher risks and are more dangerous to the consumer if used without the supervision of a doctor or health care professional. For example, warfarin (an anticoagulant or blood thinner) is a medication that requires very close monitoring to prevent stroke or death. Another example is amoxicillin and other antibiotics that should not be used for self treatment to reduce the risk of antibiotic-resistant infections. Levothyroxine, a thyroid replacement hormone, also requires close monitoring to ensure effective treatment. Another blood thinner, clopidogrel, may pose increased risk of cardiac events, such as heart attack if used in sub-optimal doses, which might be found in imported tablets.

Consumers are also at risk if the drugs are not properly labeled for safe and effective use. For example, alendronate sodium, which is used to treat and prevent osteoporosis, should include information warning patients of significant side effects if it is not taken appropriately. Imported eye drop preparations may not have been manufactured under proper conditions to ensure sterility, leaving patients susceptible to contamination that may result in serious infections. These are only a few examples demonstrating the importance of obtaining FDA-approved drugs and health care provider monitoring.

Cost Concerns
The examination of foreign mail shipments also found that about 45 percent of the imported products already are available in the United States as an FDA-approved generic drug (see Table 1). About half of these generic drugs are available through national pharmacy chain programs that offer generic prescriptions at a cost of $4 each. This cost is usually significantly less than the cost of drugs charged by Internet sellers.

FDA has documented problems with imported drug products and has taken action when possible against foreign Web sites selling counterfeit products.

FOR IMMEDIATE RELEASE
July 2, 2007

Media Inquiries:
Catherine McDermot, 301-827-6242
Consumer Inquiries:
888-INFO-FDA

www. fda.gov/bbs/topics/NEWS/2007/NEW01663.html

RELATED STORIES:
Chinese companies to make Viagra variant after Pfizer loses patent   Illumina board rejects sweetened Roche offer   Fat-fighting drugs are a far riskier business   FDA approves Atripla for the treatment of HIV-1 infection in adults   Illinois helps residents import prescription drugs   Pfizer arthritis drug gets heart test   Advair may improve COPD survival: clinical trial   Merck board names committee on Vioxx withdrawal   New FDA report says earlier meetings w/FDA make drug review process more efficient   Viagra promising in pulmonary hypertension   DEA shuts 4,600 rogue pharmacy sites   FDA Says None of Chiron Influenza Vaccine Safe for Use

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]